| scholarly article | Q13442814 |
| P2093 | author name string | Minjae Lee | |
| Yan Lin | |||
| Xin Huang | |||
| Esther Elishaev | |||
| Ted Lee | |||
| Hui-Min Lin | |||
| Suketu Mansuria | |||
| Nicole Donnellan | |||
| Gina Mantia-Smaldone | |||
| Swati Suryawanshi | |||
| Marcia Klein-Patel | |||
| Raluca Budiu | |||
| Robert P. Edwards | |||
| Robin Laskey | |||
| Anda M. Vlad | |||
| P2860 | cites work | New tumor markers: CA125 and beyond. | Q36338802 |
| Discovery and application of protein biomarkers for ovarian cancer | Q37057624 | ||
| The relationship of endometriosis and ovarian malignancy: a review | Q37321246 | ||
| Clinical practice. Screening for ovarian cancer | Q37545174 | ||
| Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin. | Q37777377 | ||
| MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease | Q39950193 | ||
| MicroRNAs and cancer: short RNAs go a long way. | Q41906288 | ||
| Extracellular miRNAs: the mystery of their origin and function | Q44235487 | ||
| Prevalence of endometriosis in malignant epithelial ovary tumours | Q44353681 | ||
| Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer | Q45201949 | ||
| Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate | Q53306425 | ||
| Malignant transformation of ovarian endometriosis | Q53403668 | ||
| Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. | Q54439228 | ||
| The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform | Q54997659 | ||
| Prognostic importance of hyperplasia and atypia in endometriosis | Q71643375 | ||
| Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone | Q71736108 | ||
| Ovarian atypical endometriosis: its close association with malignant epithelial tumours | Q73193912 | ||
| Frequency of ovarian endometriosis in epithelial ovarian cancer patients | Q83303461 | ||
| High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer | Q83943983 | ||
| A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells | Q84749347 | ||
| Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection | Q21134914 | ||
| Serum microRNAs are promising novel biomarkers | Q21144238 | ||
| Ovarian carcinoma subtypes are different diseases: implications for biomarker studies | Q21563402 | ||
| Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing | Q24570129 | ||
| ARID1A mutations in endometriosis-associated ovarian carcinomas | Q24610484 | ||
| Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies | Q24619808 | ||
| Clinical practice. Endometriosis | Q24625416 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| The role of CA125 in clinical practice | Q24672539 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| MicroRNA signatures in human ovarian cancer | Q28249211 | ||
| MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Q29614237 | ||
| Control of translation and mRNA degradation by miRNAs and siRNAs | Q29614239 | ||
| Direct multiplexed measurement of gene expression with color-coded probe pairs | Q29614417 | ||
| MicroRNAs in Cancer | Q29615539 | ||
| Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries | Q33434403 | ||
| MicroRNAs in ovarian carcinomas | Q33796565 | ||
| Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects | Q34033619 | ||
| Anti-angiogenic treatment strategies for the therapy of endometriosis | Q34283036 | ||
| Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection | Q34364165 | ||
| Cancer of the ovary | Q34375262 | ||
| Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens | Q34895083 | ||
| miR-21: a small multi-faceted RNA. | Q34931601 | ||
| Endometriosis and ovarian cancer: thoughts on shared pathophysiology | Q35177953 | ||
| Cluster analysis and related techniques in medical research | Q35243382 | ||
| Endometriosis and the neoplastic process | Q35689308 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| endometriosis | Q205764 | ||
| microRNA | Q310899 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 1213-1224 | |
| P577 | publication date | 2013-01-29 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer | |
| Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer | |||
| P478 | volume | 19 |
| Q90146216 | A Systematic Review and Bioinformatics Study on Genes and micro-RNAs Involving the Transformation of Endometriosis into Ovarian Cancer |
| Q35987412 | Absolute quantification of cell-free microRNAs in cancer patients |
| Q37386222 | Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer |
| Q35325816 | Assay reproducibility in clinical studies of plasma miRNA |
| Q33643216 | Association between social support and post-traumatic stress disorder symptoms among Chinese patients with ovarian cancer: A multiple mediation model. |
| Q41006936 | Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma. |
| Q90113970 | Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives |
| Q24185755 | Blood biomarkers for the non-invasive diagnosis of endometriosis |
| Q103796324 | Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review |
| Q28387827 | Carcinogenic activity of PbS quantum dots screened using exosomal biomarkers secreted from HEK293 cells |
| Q38842894 | Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. |
| Q38130367 | Cellular, Histologic, and Molecular Changes Associated With Endometriosis and Ovarian Cancer |
| Q89530011 | Challenges in uncovering non-invasive biomarkers of endometriosis |
| Q35799002 | Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the "old" complement pathway |
| Q28082378 | Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise |
| Q33718986 | Circulating MicroRNAs in gynecological malignancies: from detection to prediction |
| Q64963958 | Circulating miRNAs as Biomarkers for Endometriosis and Endometriosis-Related Ovarian Cancer-An Overview. |
| Q52912801 | Circulating miRNAs in Murine Experimental Endometriosis |
| Q64066220 | Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis |
| Q35562931 | Circulating microRNAs as potential biomarkers for endometriosis |
| Q26747154 | Clinical relevance of circulating cell-free microRNAs in ovarian cancer |
| Q47589569 | Comparative systems genetics view of endometriosis and uterine leiomyoma: Two sides of the same coin? |
| Q42371675 | Comprehensive analysis on diagnostic value of circulating miRNAs for patients with ovarian cancer |
| Q26768709 | Current clinical application of serum biomarkers to detect ovarian cancer |
| Q38711390 | Current status on microRNAs as biomarkers for ovarian cancer |
| Q89450623 | Diagnostic accuracy of miRNAs as potential biomarkers for systemic lupus erythematosus: a meta-analysis |
| Q55154955 | Diversity and signature of small RNA in different bodily fluids using next generation sequencing. |
| Q35835227 | Down regulation of MiR-93 contributes to endometriosis through targeting MMP3 and VEGFA |
| Q34657664 | Endometriosis and ovarian cancer. |
| Q27003273 | Endometriosis and ovarian cancer: links, risks, and challenges faced |
| Q21285103 | Endometriosis: A Disease That Remains Enigmatic |
| Q39077807 | Entangling Relation of Micro RNA-let7, miRNA-200 and miRNA-125 with Various Cancers |
| Q38141097 | Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives. |
| Q35879526 | Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients. |
| Q92544391 | Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease |
| Q58571301 | Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes |
| Q36197033 | MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1. |
| Q35854007 | MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1. |
| Q35296797 | MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3. |
| Q36623848 | MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc. |
| Q30244282 | MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications |
| Q38436356 | MicroRNAs and angiogenesis in endometriosis |
| Q39215885 | MicroRNAs-Based Imaging Techniques in Cancer Diagnosis and Therapy |
| Q38797393 | Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study |
| Q38197676 | Noninvasive biomarkers of endometriosis: myth or reality? |
| Q37645709 | Ovarian cancer in endometriosis: clinical and molecular aspects |
| Q36029643 | Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas |
| Q86653658 | Plasma MicroRNAs in Ovarian Cancer—Letter |
| Q37003004 | Plasma MicroRNAs in Ovarian Cancer—Response |
| Q36546798 | Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival |
| Q92612447 | Plasma miRNAs as biomarkers for endometriosis |
| Q35740260 | Potential role of cervicovaginal extracellular particles in diagnosis of endometriosis. |
| Q54117850 | Potential tumor suppressing role of microRNA-545 in epithelial ovarian cancer |
| Q38810117 | Recent insights on the genetics and epigenetics of endometriosis |
| Q36701651 | Research Progress of MicroRNA in Early Detection of Ovarian Cancer |
| Q38258014 | Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies |
| Q98771139 | Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned? |
| Q51026736 | Serum miR-451a Levels Are Significantly Elevated in Women With Endometriosis and Recapitulated in Baboons ( Papio anubis) With Experimentally-Induced Disease |
| Q26822881 | Systematic enrichment analysis of microRNA expression profiling studies in endometriosis |
| Q38975570 | The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma |
| Q58796878 | The Endometriotic Tumor Microenvironment in Ovarian Cancer |
| Q57288786 | The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer |
| Q49804366 | The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review |
| Q35771750 | The promise and challenge of ovarian cancer models |
| Q47652779 | The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer |
| Q34253436 | The role of microRNAs in ovarian cancer |
| Q38198366 | The validity of circulating microRNAs in oncology: five years of challenges and contradictions. |
| Q38187323 | Tumor-associated circulating microRNAs as biomarkers of cancer. |
| Q26799195 | Update on Biomarkers for the Detection of Endometriosis |
| Q39391417 | Updates and current challenges in microRNA research for personalized medicine in ovarian cancer |
| Q41615311 | Upregulation of miR-520b promotes ovarian cancer growth |
| Q49834269 | hsa-miR-1973 MicroRNA is Significantly and Differentially Expressed in MDA-MB-231 Cells of Breast Adenocarcinoma and Xenografts Derived from the Tumor |
| Q50116323 | miR-31 and miR-145 as Potential Non-Invasive Regulatory Biomarkers in Patients with Endometriosis |
| Q45931978 | miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples. |
| Q94526757 | microRNA Expression Profiling in Young Prostate Cancer Patients |
Search more.